AstraZeneca opens new $1 billion R&D center in Massachusetts
AZN Astrazeneca plc
$156.53 -0.24%
View chart & analysis → - 1AstraZeneca has opened a new research and development center in Kendall Square, Massachusetts.
- 2This investment is part of AstraZeneca's $1 billion investment scale in Massachusetts.
- 3The company announced an expected expansion of over 50% of its Massachusetts workforce over the coming years.
So what's the key point?
AstraZeneca has opened a new research facility in Massachusetts. The company plans to increase its local workforce by more than 50% through this investment.
Source Quartz +2 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.